Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-023116)

Filing Details

Accession Number:: 0001209191-11-023116
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-04-18 12:30:38
Reporting Period:: 2010-10-01

Filing Date:: 2011-04-18
Accepted Time:: 2011-04-18 12:30:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882104	Pdl Biopharma Inc.	PDLI	Biological Products, (No Disgnostic Substances) (2836)	943023969

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1356151	S Jody Lindell	C/O Pdl Biopharma, Inc. 932 Southwood Boulevard Incline Village NV 89451		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-01	285	$5.26	20,168	No	4	P	Direct
Common Stock	Acquisiton	2011-03-15	89	$5.53	20,257	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

These shares were acquired pursuant to an automatic dividend reinvestment feature managed by the reporting person's investment advisor.